Systemischer Lupus erythematodes und Beinvenenthrombosen in der Anamnese bei einer 27-j?hrigen schwangeren Patientin

详细信息    查看全文

• 作者：Dr. V. Puppe
• 关键词：Resistenz gegenüber aktiviertem Protein?C ; Hydroxychloroquin ; Schwangerschaft ; Systemischer Lupus erythematodes ; SS ; A ; Antik?rper ; Activated protein?C resistance ; Hydroxychloroquine ; Pregnancy ; Lupus erythematosus ; systemic ; SS ; A antibodies
• 刊名：Der Internist
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：56
• 期：3
• 页码：300-306
• 全文大小：397 KB
• 参考文献：1. Bergmann, (2014) Clin Chem Lab Med 52: pp. e257 CrossRef
  2. Clowse, (2006) Arthritis Rheum 54: pp. 3640 CrossRef
  3. Costedoat-Chalumeau, (2005) Autoimmun Rev 4: pp. 111 CrossRef
  4. Heilmann, (2002) Dtsch Arztebl 99: pp. A
  5. Heilmann, (2000) Geburtsh Frauenheilk 60: pp. 95 CrossRef
  6. Heilmann L, Tempelhoff FG von, Gerhold S et?al (2001) Der Einfluss thrombophiler Faktoren auf thromboembolische und andere Schwangerschaftskomplikationen. Z?Geburtshilfe Neonatol 205:128-36
  7. Hospital for Special Surgery (2011) Most women with lupus can have successful pregnancy outcomes, study finds. Science daily. http://www.sciencedaily.com/releases/2011/11/111106151157.htm. Zugegriffen: 10.?November 2013
  8. Izmirly, (2012) Circulation 126: pp. 76 CrossRef
  9. Ruiz-Irastorza, (1996) Br J Rheumatol 35: pp. 133 CrossRef
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  General Practice and Family Medicine
  Internal Medicine
  Gastroenterology
  Hepatology
  Nephrology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-1289

文摘

The case of a 27-year-old pregnant woman (gravidity?I, parity?0) diagnosed with systemic lupus erytematosus with SS-A-antibodies, activated protein?C resistance, and a heterozygous factor?V Leiden mutation is presented. Thus, the pregnancy was considered a high-risk pregnancy. Many complications are associated with these diseases, which is why the pregnant woman and her unborn baby needed increased surveillance by internists and obstetricians (laboratory values, clinical symptoms, ultrasound examination). Her current medication with hydroxychloroquine was continued. In addition, low molecular weight heparin was given for thromboprophylaxis.